What is the clinical significance of filamentous fungi positive sputum cultures in patients with cystic fibrosis?

Journal of Cystic Fibrosis

Volumn 12, Issue 3, 2013, Pages 187-193

  Liu, Jane C ^a   Modha, Deborah E ^b   Gaillard, Erol A ^c  

^a MUSGROVE PARK HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Adults; Aspergillus spp.; Children; Cystic fibrosis; Fungi; Laboratory; Sputum

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; COLISTIN; ITRACONAZOLE; TOBRAMYCIN; VORICONAZOLE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIBIOTIC THERAPY; ASPERGILLUS FUMIGATUS; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; HUMAN; LABORATORY TEST; LUNG DISEASE; OBSERVATIONAL STUDY; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; REVIEW; SPUTUM CULTURE; TREATMENT DURATION;

CYSTIC FIBROSIS; FUNGI; HUMANS; MYCOSES; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 84876985774     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.02.003     Document Type: Review

References (34)

1. Dodge J.A., Lewis P.A., Stanton M., Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007, 29:522-526.
2. + channel and airway surface liquid volume by serine proteases. Pflugers Arch 2010, 460:1-17.
3. Saunders R., Modha D., Claydon A., Gaillard E. Chronic A. fumigatus colonisation of the cystic fibrosis airway is common and may be associated with a more rapid decline in lung function. J Cyst Fibros 2011, 10(Suppl. 1):S37.
4. Report of the UK Cystic Fibrosis Trust Antibiotic Working Group Antibiotic treatment for cystic fibrosis. The Cystic Fibrosis Trust May 2009, Available from: http://www.cftrust.org.uk/aboutcf/publications/consensusdoc/Antibiotic_treatment_for_Cystic_Fibrosis.pdf. 3rd ed.
5. Bauernfeind A., Bertele R.M., Harms K., Hörl G., Jungwirth R., Petermüller C., et al. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection 1987, 15:270-277.
6. de Valk H.A., Klaassen C.H., Yntema J.B., Hebestreit A., Seidler M., Haase G., et al. Molecular typing and colonization patterns of A. fumigatus in patients with cystic fibrosis. J Cyst Fibros 2009, 8:110-114.
7. Neuvéglise C., Sarfati J., Debeaupuis J.P., Vu Thien H., Just J., Tournier G., et al. Longitudinal study of A. fumigatus strains isolated from cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1997, 16:747-750.
8. Thia L.P., Balfour Lynn I.M. Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Paediatr Respir Rev 2009, 10:37-42.
9. Mroueh S., Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 1994, 105:32-36.
10. Cimon B., Carrère J., Chazalette J.P., Giniès J.L., Six P., Vinatier J.F., et al. Fungal colonization and immune response to fungi in cystic fibrosis. J Mycol Méd 1995, 5:211-216.
11. Milla C.E., Wielinski C.L., Regelmann W.E. Clinical significance of the recovery of Aspergillus spp. species from the respiratory secretions of cystic fibrosis patients. Pediatr Pulmonol 1996, 21:6-10.
12. Bargon J., Dauletbaev N., Köhler B., Wolf M., Posselt H.G., Wagner T.O. Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus spp. colonization in adult cystic fibrosis patients. Respir Med 1999, 93:835-838.
13. Bakare N., Rickerts V., Bargon J., Just-Nübling G. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 2003, 46:19-23.
14. Valenza G., Tappe D., Turnwald D., Frosch M., König C., Hebestreit H., et al. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros 2008, 7:123-127.
15. Amin R., Dupuis A., Aaron S.D., Ratjen F. The effect of chronic infection with A. fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 2010, 137:171-176.
16. Jubin V., Ranque S., Stremler Le Bel N., Sarles J., Dubus J.C. Risk factors for Aspergillus spp. colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Pediatr Pulmonol 2010, 45:764-771.
17. Paugam A., Baixench M.T., Demazes-Dufeu N., Burgel P.R., Sauter E., Kanaan R., et al. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol 2010, 48(Suppl. 1):S32-S36.
18. de Vrankrijker A.M., Van Der Ent C.K., Van Berkhout F.T., Stellato R.K., Willems R.J., Bonten M.J., et al. A. fumigatus colonisation in cystic fibrosis: implications for lung function?. Clin Microbiol Infect 2011, 17:1381-1386.
19. Cimon B., Symoens F., Zouhair R., et al. Molecular epidemiology of airway colonisation by A. fumigatus in cystic fibrosis patients. J Med Microbiol 2001, 50:367-374.
20. Millar F.A., Simmonds N.J., Hodson M.E. Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005. J Cyst Fibros 2009, 8:386-391.
21. Corey M. Canadian Cystic Fibrosis Patient Registry 2001, Canadian Cystic Fibrosis Foundation.
22. Cystic Fibrosis Canada Canadian Cystic Fibrosis Patient Data Registry Report 2009 2009, Cystic Fibrosis Canada, Available: http://www.cysticfibrosis.ca/assets/files/pdf/CPDR_ReportE.pdf. Accessed 2011 Dec 2.
23. Health Protection Agency United Kingdom National Standard Method. Investigation of bronchoalveolar lavage sputum and associated specimens. BSOP 57. Issued by Standards Unit, Department for Evaluations, Standards and Training Centre for Infections Available from;. http://www.hpastandardmethods.org.uk/documents/bsop/pdf/bsop57.pdf.
24. Pashley C.H., Fairs A., Morley J.P., Tailor S., Agbetile J., Bafadhel M., et al. Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence. Med Mycol 2012, 50:433-438.
25. Nagano Y., Millar B.C., Goldsmith C.E., Walker J.M., Elborn J.S., Rendall J., et al. Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF). J Cyst Fibros 2008, 7:566-572.
26. Borman A.M., Palmer M.D., Delhaes L., Carrère J., Favennec L., Ranque S., et al. Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi. Med Mycol 2010, 48(Suppl. 1):S88-S97.
27. Burns J.L., Emerson J., Stapp J.R., Yim D.L., Krzewinski J., Louden L., et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998, 27:158-163.
28. Hodson M.E., Gallagher C.G., Govan J.R.W. A randomized clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Eur Respir J 2002, 20:658-664.
29. Amitani R., Murayama T., Nawada R., Lee W.J., Niimi A., Suzuki K., et al. Aspergillus spp. culture filtrates and sputum sols from patients with pulmonary aspergillosis cause damage to human respiratory ciliated epithelium in vitro. Eur Respir J 1995, 8:1681-1687.
30. Kerr J.R., Taylor G.W., Rutman A., Høiby N., Cole P.J., Wilson R. Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J Clin Pathol 1999, 52:385-387.
31. Aaron S.D., Vandemheen K.L., Freitag A., Pedder L., Cameron W., Lavoie A., et al. Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study. PLoS One 2012, 7(4):e36077.
32. Kanthan S.K., Bush A., Kemp M., Buchdahl R. Factors effecting impact of A. fumigatus sensitization in cystic fibrosis. Pediatr Pulmonol 2007, 42:785-793.
33. Hilliard T., Edwards S., Buchdahl R., Francis J., Rosenthal M., Balfour-Lynn I., et al. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros 2005, 4:215-220.
34. Shoseyov D., Brownlee K.G., Conway S.P., Kerem E. Aspergillus spp. bronchitis in cystic fibrosis. Chest 2006, 130:222-226.